Effect of liposome encapsulated hemoglobin 'Neo Red Cells' on severe hemorrhagic shock

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 4, 1997, Pages 379-392

  Usuba, Akira ^a   Motoki, Ryoichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENCAPSULATION; HEMODYNAMICS; HEMOGLOBIN; LIVING SYSTEMS STUDIES; OXYGEN; TRANSPORT PROPERTIES; VISCOSITY OF LIQUIDS;

HEMORRHAGIC SHOCK; LIPOSOMES; NEO RED CELLS;

CELLS;

HEMOGLOBIN; LIPOSOME; OXYGEN;

ANIMAL EXPERIMENT; ARTICLE; ERYTHROCYTE; HEART OUTPUT; HEMODYNAMICS; HEMORRHAGIC SHOCK; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ANIMALIA;

EID: 0031194536     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709118928     Document Type: Article

References (22)

1. Clark LC, Gollan F, Survival of mammals breathing organic liquids equilibrated with oxygen atmospheric pressure, Science, 152, 1755-1756, (1966)
2. Honda K, Hoshino S, Shoji M, Usuba A, Motoki R, Tsuboi M, Inoue H, Iwaya F, Clinical use of blood substitute, N Engl J Med , 303, 391-392, (1980)
3. Marwick C, FDA committee questions Fluosol efficacy; US approval not imminent, JAMA, 250, 2585-2586, (1983)
4. Mitsuno T, Ohyanagi H, Naito R, Clinical studies of perfluorochemical whole blood substitute (Fluosol-DA), Ann Surg, 195, 60-69, (1982)
5. Djordjevich L, Miller IF, Synthetic erythrocytes from lipid encapsulated hemoglobin, Exp Hematol, 8, 584-592, (1980)
6. Farmer MC, Gaber BP, Liposome encapsulated hemoglobin as an artificial oxygen-carryingsystem, Methods Enzymol, 149, 184-200, (1987)
7. Hunt CA, Burnette RR, MacGrogor RD, Strubbe AE, Lau DT, Taylor N, Kawada H, Synthesis and evaluation of a prototypal artificial red cell, Science, 230, 1165-1168, (1985)
8. Iwasaki K, Iwashita Y, Preparation and evaluation of hemoglobin polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid, Artif Organs, 10, 411-416, (1986)
9. Clerc Y, Dubos M, Bihoreau N, Delamourd L, Brasseur C, Gond B, Goyffon M, Saint-Blancard J, Pyridoxylated polymerized hemoglobin solution processing. Interest of a membrane molecular fractionation step, Appl Biochem Biotechnol, 14, 241-251, (1987)
10. Snyder SR, Welty EV, Walder RY, Williams LA, Walder TA, HbxL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute, Proc Nat Acad Sci USA, 84, 7280-7284, (1987)
11. Winslow RM, Blood substitute oxygen carriers designed for clinical applications, in Winslow RM, Vandegriff KD, Intaglietta M, eds, Blood substitutes: new challenges, Birkhauser, Boston, 60-72, (1996)
12. Rudolph AS, Encapsulation of hemoglobin in liposomes, in Winslow RM, Vandegriff KD, Intaglietta M, eds, Blood substitutes : physiological basis of efficacy, Birkhauser, Boston, 90-104, (1995)
13. Usuba A, Motoki R, Ogata Y, Suzuki K, Kamitani T, Effect and safety of liposome-encapsulated hemoglobin neo red cells (NRCs) as a perfusate for total cardiopulmonary bypass, Art Cells Blood Subs and Immob Biotech, 23, 337-346, (1995)
14. Usuba A, Motoki R, Safety and efficacy of encapsulated hemoglobin in hemorrhagic shock, in Tsuchida eds, Artificial red cells, John Wiley & Sons, New York, 65-92, (1995)
15. Usuba A, Endoh Y, Motoki R, Ogata Y, Suzuki K, Kamitani T, Neo red cells in a canine hemorrhagic shock model, in Shek PN eds, Liposomes in biomedical applications, Harwood academic publishers, Amsterdam, 265-281, (1995)
16. Honda K, Usuba A, Miyazawa M, Motoki R, Kanno M, Honda M, Iwaya F, Hoshino S, Yamanouchi K, Yokoyama K, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A, Development of artificial blood; from Fluosol-DA (FDA) to neo red cells (NRC), Biomater-Living Syst Interact, 1, 73-84, (1993)
17. Usuba A, Motoki R, Miyauchi Y, Suzuki K, Takahashi A, Effect of neo red cells on the canine hemorrhagic shock model, Int J Artif Organs, 14, 739-744, (1991)
18. Usuba A, Motoki R, Suzuki K, Sakaguchi K, Takahashi A, Study of the effect of the newly developed artificial blood "neo red cells (NRC)" on hemodynamics and blood gas transport in canine hemorrhagic shock, Biomater Artif Cells Immobil Biotechnol, 20, 531-535, (1992)
19. Usuba A, Motoki R, Sakaguchi K, Suzuki K, Kamitani T, Effect of neo red cells on the hemodynamics and blood gas transport in canine hemorrhagic shock and its safety for vital organs, Biomater Art Cells Blood Subs and Immob Biotech, 22, 503-516, (1994)
20. Usuba A, Motoki R, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A, Oxygen transport capacity and hemodynamic effect of newly developed artificial blood "neo red cells (NRC)", in XX VIII World congress of the International College of Surgeons, Monduzzi Editore, Bologna, 803-806, (1992)
21. Usuba A, Miyazawa M, Miura J, Endoh Y, Motoki R, Sakaguchi K, Suzuki K, Takahashi A, Oxygentransport capacity and hemodynamic effects of newly developed artificial blood "neo red cells (NRC)", Artif Organs Today, 2, 299-308, (1993)
22. Usuba A, Miyazawa M, Motoki R, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A, Oxygentransport capacity and hemodynamic effect of newly developed artificial blood "neo red cells (NRC)" , Int J Artif Organs, 16, 551-556, (1993)